Bio-Path Holdings Statistics
Total Valuation
BPTH has a market cap or net worth of $4.20 million. The enterprise value is $3.26 million.
| Market Cap | 4.20M |
| Enterprise Value | 3.26M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BPTH has 1.57 million shares outstanding. The number of shares has increased by 31.32% in one year.
| Shares Outstanding | 1.57M |
| Shares Change (YoY) | +31.32% |
| Shares Change (QoQ) | -4.90% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 1.80% |
| Float | 654,562 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 9.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.60 |
| Quick Ratio | n/a |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -375.70% and return on invested capital (ROIC) is -2,859.75%.
| Return on Equity (ROE) | -375.70% |
| Return on Assets (ROA) | -248.60% |
| Return on Capital (ROIC) | -2,859.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.61M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.02% in the last 52 weeks. The beta is 0.38, so BPTH's price volatility has been lower than the market average.
| Beta (1Y) | 0.38 |
| 52-Week Price Change | -89.02% |
| 50-Day Moving Average | 4.86 |
| 200-Day Moving Average | 9.27 |
| Relative Strength Index (RSI) | 35.37 |
| Average Volume (30 Days) | 1,445,593 |
Short Selling Information
The latest short interest is 27,365, so 1.75% of the outstanding shares have been sold short.
| Short Interest | 27,365 |
| Short Previous Month | 67,406 |
| Short % of Shares Out | 1.75% |
| Short % of Float | 4.18% |
| Short Ratio (days to cover) | 0.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.84M |
| Pretax Income | -16.08M |
| Net Income | -16.08M |
| EBITDA | -15.90M |
| EBIT | -16.08M |
| Earnings Per Share (EPS) | -$33.63 |
Balance Sheet
The company has $1.05 million in cash and $113,000 in debt, giving a net cash position of $939,000 or $0.60 per share.
| Cash & Cash Equivalents | 1.05M |
| Total Debt | 113,000 |
| Net Cash | 939,000 |
| Net Cash Per Share | $0.60 |
| Equity / Book Value | 441,000 |
| Book Value Per Share | 0.28 |
| Working Capital | 1.14M |
Cash Flow
| Operating Cash Flow | -11.54M |
| Capital Expenditures | n/a |
| Free Cash Flow | -11.54M |
| FCF Per Share | -$24.13 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BPTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.32% |
| Shareholder Yield | -31.32% |
| Earnings Yield | -383.26% |
| FCF Yield | -274.97% |
Analyst Forecast
The average price target for BPTH is $40.00, which is 1,392.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.00 |
| Price Target Difference | 1,392.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 23, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 23, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |